These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Large-scale secretome analyses unveil the superior immunosuppressive phenotype of umbilical cord stromal cells as compared to other adult mesenchymal stromal cells. Islam A; Urbarova I; Bruun JA; Martinez-Zubiaurre I Eur Cell Mater; 2019 Feb; 37():153-174. PubMed ID: 30785213 [TBL] [Abstract][Full Text] [Related]
43. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases. Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107 [TBL] [Abstract][Full Text] [Related]
44. Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Najar M; Rouas R; Raicevic G; Boufker HI; Lewalle P; Meuleman N; Bron D; Toungouz M; Martiat P; Lagneaux L Cytotherapy; 2009; 11(5):570-83. PubMed ID: 19565371 [TBL] [Abstract][Full Text] [Related]
45. Vitamin K2 Suppresses Proliferation and Inflammatory Cytokine Production in Mitogen-Activated Lymphocytes of Atopic Dermatitis Patients through the Inhibition of Mitogen-Activated Protein Kinases. Zhang M; Miura T; Suzuki S; Chiyotanda M; Tanaka S; Sugiyama K; Kawashima H; Hirano T Biol Pharm Bull; 2021; 44(1):7-17. PubMed ID: 33390552 [TBL] [Abstract][Full Text] [Related]
47. Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge. Boland LK; Burand AJ; Boyt DT; Dobroski H; Di L; Liszewski JN; Schrodt MV; Frazer MK; Santillan DA; Ankrum JA Front Immunol; 2019; 10():1080. PubMed ID: 31134100 [TBL] [Abstract][Full Text] [Related]
48. Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach. Chinnadurai R; Rajan D; Qayed M; Arafat D; Garcia M; Liu Y; Kugathasan S; Anderson LJ; Gibson G; Galipeau J Cell Rep; 2018 Feb; 22(9):2504-2517. PubMed ID: 29490284 [TBL] [Abstract][Full Text] [Related]
49. In vitro Immunomodulatory Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells on Peripheral Blood Cells from Warm Autoimmune Hemolytic Anemia Patients. Ma C; Feng Y; Yang L; Wang S; Sun X; Tai S; Guan X; Wang D; Yu Y Acta Haematol; 2022; 145(1):63-71. PubMed ID: 34284381 [TBL] [Abstract][Full Text] [Related]
50. Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells. Wang LT; Jiang SS; Ting CH; Hsu PJ; Chang CC; Sytwu HK; Liu KJ; Yen BL Stem Cells; 2018 Jun; 36(6):903-914. PubMed ID: 29396902 [TBL] [Abstract][Full Text] [Related]
51. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164 [TBL] [Abstract][Full Text] [Related]
52. Allogeneic chondrogenically differentiated human mesenchymal stromal cells do not induce immunogenic responses from T lymphocytes in vitro. Kiernan CH; Hoogduijn MJ; Franquesa M; Wolvius EB; Brama PAJ; Farrell E Cytotherapy; 2016 Aug; 18(8):957-969. PubMed ID: 27288309 [TBL] [Abstract][Full Text] [Related]
53. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease. Tobin LM; Healy ME; English K; Mahon BP Clin Exp Immunol; 2013 May; 172(2):333-48. PubMed ID: 23574329 [TBL] [Abstract][Full Text] [Related]
54. Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft Petinati N; Kapranov N; Davydova Y; Bigildeev A; Pshenichnikova O; Karpenko D; Drize N; Kuzmina L; Parovichnikova E; Savchenko V World J Stem Cells; 2020 Nov; 12(11):1377-1395. PubMed ID: 33312405 [TBL] [Abstract][Full Text] [Related]
55. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes. Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784 [TBL] [Abstract][Full Text] [Related]
56. Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg/Th17 balance to promote gastric cancer progression. Wang M; Chen B; Sun XX; Zhao XD; Zhao YY; Sun L; Xu CG; Shen B; Su ZL; Xu WR; Zhu W Exp Cell Res; 2017 Dec; 361(1):19-29. PubMed ID: 28964780 [TBL] [Abstract][Full Text] [Related]
57. Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes. Del Fattore A; Luciano R; Pascucci L; Goffredo BM; Giorda E; Scapaticci M; Fierabracci A; Muraca M Cell Transplant; 2015; 24(12):2615-27. PubMed ID: 25695896 [TBL] [Abstract][Full Text] [Related]
58. Human Adipose Tissue-Derived Mesenchymal Stromal Cells Inhibit CD4+ T Cell Proliferation and Induce Regulatory T Cells as Well as CD127 Expression on CD4+CD25+ T Cells. Fiori A; Uhlig S; Klüter H; Bieback K Cells; 2021 Jan; 10(1):. PubMed ID: 33401501 [TBL] [Abstract][Full Text] [Related]